Most recently, Bullock was president and CEO of Atritech Inc which was recently sold to Boston Scientific. Prior to Atritech, he was president and CEO of Endocardial So...
You must be logged in to view the whole article.
Click here if you require signing up
GlaxoSmithKline says several board members will not stand for re-election
LoneStar Heart appoints Names Andrew Coats, Mark Maciejewski to board of directors
Gerald Storch joins Bristol-Myers Squibb's board of directors
Cleveland BioLabs shakes up management
Claude Allary to serve as special advisor to Arch Biopartners